Company Directory / research

PrivateFor profitresearchRedwood City, United States
Biotechnology company developing combination therapeutics for cancer
Size
1-10 people: larger than 0% of companies with a size listed
Age
5 years old.
Reach
Website ranked #8,491,981 in the world for traffic, about 523 visits a month.
BiotechnologyLife Science
Funding, as listed
$7.0M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Eigen Therapeutics, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Eigen Therapeutics may be growing as it has successfully raised $7 million in seed funding, which is a strong indicator of investor confidence and provides capital for research, development, and potential expansion. This influx of funds can be pivotal for a biotechnology company in the early stages of developing combination therapeutics for cancer, as it allows for the advancement of research and the potential for bringing new treatments to market. The seed funding also suggests that the company has met certain milestones or presented promising data to attract this level of investment.
Summaries written by the source dataset, not by us, and not checked.
research in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.